A higher spectral range of beetle bioluminescence with infraluciferin by Amit P. Jathoul, Amit P. Jathoul, Bruce R. Branchini, James C. Anderson, James A. H. Murray

Get full text

Mechanical Characteristics and Regression Models of Rice Husk Silica Reinforced Natural Rubber Composites by P. A. Ubi, N. A. Ademoh, A. S. Abdulrahman, A. B. Hassan, J. D. Dashe, S. W. Oyeyemi, F. Ngolomasango

Get full text

Acknowledgment of Reviewers 2021

“…Yu Qian Anirudh Rao Katherine Recka Shayna Rich Julia Ridley Emily Rivet Mark Robinson Barbara Rose Drew Rosielle Srikanth S Megan Schaefer Johannah Scheurer Pia Schmidt Stephanie Schmitt Craig Sellers Valgerdur Sigurdardottir Steffen Simon Michael Spiker Mark Stoltenberg Zhuolu Sun Koichi Taira Audrey Tan John Tangeman Marieke Torensma Alexia Torke Amy Trowbridge Hector Tsang Rose Maria van Zuilen Zhu Wang Jennifer Winegarden Ru Wong Brooke Worster Takashi Yamaguchi Shintaro Yanazume Grace Yang Deokhee Yi Janelle Yorke Jasmine Zheng Gregory Zumach …”
Get full text

A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm inf... by Costeloe, K, Bowler, U, Brocklehurst, P, Hardy, P, Heal, P, Juszczak, E, King, A, Panton, N, Stacey, F, Whiley, A, Wilks, M, Millar, M

“…Exclusions included life-threatening or any gastrointestinal malformation detected within 48 hours of birth and no realistic chance of survival.Active intervention: 1 ml of B. breve BBG-001 in one-eighth-strength infant formula Neocate(®) (Nutricia Ltd, Trowbridge, UK), (6.7 × 10(7) to 6.7 × 10(9) colony-forming units) per dose administered enterally. …”

A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm inf... by Kate Costeloe, Ursula Bowler, Peter Brocklehurst, Pollyanna Hardy, Paul Heal, Edmund Juszczak, Andy King, Nicola Panton, Fiona Stacey, Angela Whiley, Mark Wilks, Michael R Millar

“…Interventions: Active intervention: 1 ml of B. breve BBG-001 in one-eighth-strength infant formula Neocate® (Nutricia Ltd, Trowbridge, UK), (6.7 × 107 to 6.7 × 109 colony-forming units) per dose administered enterally. …”
Get full text